Skip to main content
Erschienen in: Lung 6/2021

24.11.2021 | HYPEROXIA-INDUCED LUNG INJURY

ETS1 Ameliorates Hyperoxia-Induced Alveolar Epithelial Cell Injury by Regulating the TGM2-Mediated Wnt/β-Catenin Pathway

verfasst von: Min Yang, Xi-Rong Gao, Yan-Ni Meng, Fang Shen, Yan-Ping Chen

Erschienen in: Lung | Ausgabe 6/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Bronchopulmonary dysplasia (BPD) is a chronic lung disease that affects newborns who need oxygen therapy, and high-concentration oxygen therapy may cause neonatal morbidity and mortality in newborns. E26 oncogene homologue 1 (ETS1) and transglutaminase 2 (TGM2) have been reported to be associated with lung cell injury. However, the mechanism of ETS1 in regulating BPD is still unclear.

Methods

Hyperoxia-induced A549 cells to simulate hyperoxia-induced alveolar epithelial cell injury. MTT assays and colony formation assays were performed to investigate the proliferation of A549 cells. Flow cytometry was carried out to quantify the apoptosis of A549 cells. The expression levels of ETS1 and TGM2 were quantified by qRT–PCR. The protein expression levels of ETS1, TGM2, β-catenin, c-Jun and MET were measured by western blot. Overexpression of ETS1, overexpression of TGM2, overexpression of ETS1 with downregulation of TGM2 and overexpression of TGM2 with inhibition of Wnt/β-catenin pathway were performed to investigate the role of ETS1, TGM2 and Wnt/β-catenin pathways in hyperoxia-induced alveolar epithelial cell injury.

Results

Hyperoxia decreased the proliferation and promoted the apoptosis of cells in a time-dependent manner. Moreover, overexpression of ETS1 rescued the effect of hyperoxia on proliferation and apoptosis. In addition, overexpression of TGM2 participated in the regulation of hyperoxia-induced proliferation and apoptosis. ETS1 regulated hyperoxia-induced alveolar epithelial cell injury through the Wnt/β-catenin pathway via TGM2.

Conclusion

ETS1 ameliorates hyperoxia-induced alveolar epithelial cell injury through the TGM2-mediated Wnt/β-catenin pathway.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Haggie S et al (2020) Bronchopulmonary dysplasia: a review of the pulmonary sequelae in the post-surfactant era. J Paediatr Child Health 56(5):680–689CrossRef Haggie S et al (2020) Bronchopulmonary dysplasia: a review of the pulmonary sequelae in the post-surfactant era. J Paediatr Child Health 56(5):680–689CrossRef
2.
Zurück zum Zitat Varghese N, Rios D (2019) Pulmonary hypertension associated with bronchopulmonary dysplasia: a review. Pediatr Allergy Immunol Pulmonol 32(4):140–148CrossRef Varghese N, Rios D (2019) Pulmonary hypertension associated with bronchopulmonary dysplasia: a review. Pediatr Allergy Immunol Pulmonol 32(4):140–148CrossRef
3.
Zurück zum Zitat Siffel C et al (2019) Global incidence of bronchopulmonary dysplasia among extremely preterm infants: a systematic literature review. J Matern-Fetal Neonatal Med 34:1721–1731CrossRef Siffel C et al (2019) Global incidence of bronchopulmonary dysplasia among extremely preterm infants: a systematic literature review. J Matern-Fetal Neonatal Med 34:1721–1731CrossRef
4.
Zurück zum Zitat Morris IP, Goel N, Chakraborty M (2019) Efficacy and safety of systemic hydrocortisone for the prevention of bronchopulmonary dysplasia in preterm infants: a systematic review and meta-analysis. Eur J Pediatr 178(8):1171–1184CrossRef Morris IP, Goel N, Chakraborty M (2019) Efficacy and safety of systemic hydrocortisone for the prevention of bronchopulmonary dysplasia in preterm infants: a systematic review and meta-analysis. Eur J Pediatr 178(8):1171–1184CrossRef
5.
Zurück zum Zitat Mosca F, Colnaghi M, Fumagalli M (2011) BPD: old and new problems. J Matern Fetal Neonatal Med 24(Suppl 1):80–82CrossRef Mosca F, Colnaghi M, Fumagalli M (2011) BPD: old and new problems. J Matern Fetal Neonatal Med 24(Suppl 1):80–82CrossRef
7.
Zurück zum Zitat Guo MH et al (2013) The influence of BCSG1 siRNA on gene expression of BCSG1 in human breast cancer and the expression of S-100A4, ETS1, VEGF and CD105 in human breast tumor. Int J Mol Med 32:S74–S74 Guo MH et al (2013) The influence of BCSG1 siRNA on gene expression of BCSG1 in human breast cancer and the expression of S-100A4, ETS1, VEGF and CD105 in human breast tumor. Int J Mol Med 32:S74–S74
8.
Zurück zum Zitat Kars MD, Iseri OD, Gunduz U (2010) Drug resistant breast cancer cells overexpress ETS1 gene. Biomed Pharmacother 64(7):458–462CrossRef Kars MD, Iseri OD, Gunduz U (2010) Drug resistant breast cancer cells overexpress ETS1 gene. Biomed Pharmacother 64(7):458–462CrossRef
10.
Zurück zum Zitat Yang M et al (2017) Angiogenesis-related genes may be a more important factor than matrix metalloproteinases in bronchopulmonary dysplasia development. Oncotarget 8(12):18670–18679CrossRef Yang M et al (2017) Angiogenesis-related genes may be a more important factor than matrix metalloproteinases in bronchopulmonary dysplasia development. Oncotarget 8(12):18670–18679CrossRef
12.
Zurück zum Zitat Hadchouel A et al (2008) Matrix metalloproteinase gene polymorphisms and bronchopulmonary dysplasia: identification of MMP16 as a new player in lung development. Plos One 3(9):e3188CrossRef Hadchouel A et al (2008) Matrix metalloproteinase gene polymorphisms and bronchopulmonary dysplasia: identification of MMP16 as a new player in lung development. Plos One 3(9):e3188CrossRef
13.
Zurück zum Zitat Kim JH et al (2012) Effects of transglutaminase 2 inhibition in ventilator-induced lung injury. Respirology 17:65–65CrossRef Kim JH et al (2012) Effects of transglutaminase 2 inhibition in ventilator-induced lung injury. Respirology 17:65–65CrossRef
14.
Zurück zum Zitat Lee MY et al (2018) Tissue transglutaminase 2 expression is epigenetically regulated in human lung cancer cells and prevents reactive oxygen species-induced apoptosis. Cancer Manag Res 10:2835–2848CrossRef Lee MY et al (2018) Tissue transglutaminase 2 expression is epigenetically regulated in human lung cancer cells and prevents reactive oxygen species-induced apoptosis. Cancer Manag Res 10:2835–2848CrossRef
15.
Zurück zum Zitat Witsch TJ et al (2014) Transglutaminase 2: a new player in bronchopulmonary dysplasia? Eur Respir J 44(1):109–121CrossRef Witsch TJ et al (2014) Transglutaminase 2: a new player in bronchopulmonary dysplasia? Eur Respir J 44(1):109–121CrossRef
17.
Zurück zum Zitat Syed M et al (2017) Hyperoxia causes miR-34a-mediated injury via angiopoietin-1 in neonatal lungs. Nat Commun 8(1):1173CrossRef Syed M et al (2017) Hyperoxia causes miR-34a-mediated injury via angiopoietin-1 in neonatal lungs. Nat Commun 8(1):1173CrossRef
18.
Zurück zum Zitat Abdul-Hafez A, Mohamed T, Uhal BD (2019) Activation of mas restores hyperoxia-induced loss of lung epithelial barrier function through inhibition of apoptosis. J Lung Pulm Respir Res 6(3):58–62PubMedPubMedCentral Abdul-Hafez A, Mohamed T, Uhal BD (2019) Activation of mas restores hyperoxia-induced loss of lung epithelial barrier function through inhibition of apoptosis. J Lung Pulm Respir Res 6(3):58–62PubMedPubMedCentral
19.
Zurück zum Zitat Tiwari KK et al (2014) Differential concentration-specific effects of caffeine on cell viability, oxidative stress, and cell cycle in pulmonary oxygen toxicity in vitro. Biochem Biophys Res Commun 450(4):1345–1350CrossRef Tiwari KK et al (2014) Differential concentration-specific effects of caffeine on cell viability, oxidative stress, and cell cycle in pulmonary oxygen toxicity in vitro. Biochem Biophys Res Commun 450(4):1345–1350CrossRef
20.
Zurück zum Zitat Jia X et al (2021) YAP and Wnt3a independently promote AECIIs proliferation and differentiation by increasing nuclear betacatenin expression in experimental bronchopulmonary dysplasia. Int J Mol Med 47(1):195–206CrossRef Jia X et al (2021) YAP and Wnt3a independently promote AECIIs proliferation and differentiation by increasing nuclear betacatenin expression in experimental bronchopulmonary dysplasia. Int J Mol Med 47(1):195–206CrossRef
21.
Zurück zum Zitat Yang P et al (2019) TGM2 interference regulates the angiogenesis and apoptosis of colorectal cancer via Wnt/beta-catenin pathway. Cell Cycle 18(10):1122–1134CrossRef Yang P et al (2019) TGM2 interference regulates the angiogenesis and apoptosis of colorectal cancer via Wnt/beta-catenin pathway. Cell Cycle 18(10):1122–1134CrossRef
22.
Zurück zum Zitat Chen G, Sun X, Dong C (2017) RhoA regulates lipopolysaccharideinduced lung cell injury via the Wnt/betacatenin pathway. Mol Med Rep 16(6):8501–8506CrossRef Chen G, Sun X, Dong C (2017) RhoA regulates lipopolysaccharideinduced lung cell injury via the Wnt/betacatenin pathway. Mol Med Rep 16(6):8501–8506CrossRef
23.
Zurück zum Zitat Cheng L et al (2018) Wnt/beta-catenin pathway promotes acute lung injury induced by LPS through driving the Th17 response in mice. Biochem Biophys Res Commun 495(2):1890–1895CrossRef Cheng L et al (2018) Wnt/beta-catenin pathway promotes acute lung injury induced by LPS through driving the Th17 response in mice. Biochem Biophys Res Commun 495(2):1890–1895CrossRef
24.
Zurück zum Zitat Dasgupta C et al (2009) Hyperoxia-induced neonatal rat lung injury involves activation of TGF-{beta} and Wnt signaling and is protected by rosiglitazone. Am J Physiol Lung Cell Mol Physiol 296(6):L1031–L1041CrossRef Dasgupta C et al (2009) Hyperoxia-induced neonatal rat lung injury involves activation of TGF-{beta} and Wnt signaling and is protected by rosiglitazone. Am J Physiol Lung Cell Mol Physiol 296(6):L1031–L1041CrossRef
Metadaten
Titel
ETS1 Ameliorates Hyperoxia-Induced Alveolar Epithelial Cell Injury by Regulating the TGM2-Mediated Wnt/β-Catenin Pathway
verfasst von
Min Yang
Xi-Rong Gao
Yan-Ni Meng
Fang Shen
Yan-Ping Chen
Publikationsdatum
24.11.2021
Verlag
Springer US
Erschienen in
Lung / Ausgabe 6/2021
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-021-00489-9

Weitere Artikel der Ausgabe 6/2021

Lung 6/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.